iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Top stocks for today - 8th November 2024

8 Nov 2024 , 09:31 AM

Here are some of the stocks that may see significant price movement today.

Wipro: The IT services company announced the launch of the Google Gemini Experience Zone, aiming to accelerate AI-driven innovation for enterprises.

Lupin: Pharma company Lupin reported a 74.1% year-on-year (YoY) jump in consolidated net profit, reaching ₹852.63 crore for the July-September quarter of FY25, driven by higher sales. The Mumbai-based firm recorded revenue of ₹5,672.73 crore, up 12.6% YoY.

Cummins India: The unit of the US-based truck engine manufacturer posted a higher profit for the second quarter, reaching ₹449 crore, marking a 36.5% year-on-year (YoY) increase. This growth was driven by strong demand for its engines and power generators.

RVNL: The state-run railway company reported a 27.24% year-on-year decline in net profit for the September 2024 quarter, amounting to ₹286.88 crore. Revenue from operations fell by 1.21% to ₹4,854.95 crore during this period. EBITDA decreased by 9% year-on-year to ₹271.5 crore, with margins dropping 40 basis points to 5.6% for the quarter.

NHPC: The PSU utility company reported a 41% decline in consolidated net profit to ₹909 crore for the second quarter ended September 2024. Revenue from operations for the July-September 2024 period rose 4% year-on-year to ₹3,052 crore.

IRCON International: The railway firm posted a 17.9% year-on-year decline in net profit to ₹206 crore for the September 2024 quarter. Revenue fell by 19.3% year-on-year to ₹2,447.5 crore. EBITDA dropped by over 23% to ₹201 crore for the quarter.

Embassy REIT: The real estate investment trust has named Ritwik Bhattacharjee as its interim CEO. Bhattacharjee, formerly the Chief Investment Officer, has been part of the REIT since its listing and was a founding member of the team instrumental in the 2019 listing of Embassy REIT.

Emcure Pharma: The newly listed pharmaceutical company reported a 38.2% year-on-year (YoY) increase in net profit, reaching ₹202 crore in Q2FY25. This growth was driven by strong performance in both its domestic and international markets.

Related Tags

  • stocks in news
  • stocks to watch
  • Top stocks in news
  • top stocks today
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.